ALPHA (0303) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ALPHA (0303) has a cash flow conversion efficiency ratio of 0.054x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM11.01 Million ≈ $2.76 Million USD) by net assets (RM202.29 Million ≈ $50.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 0303 equity to assets ratio to measure how much of total assets are equity-financed.
ALPHA - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how ALPHA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 0303 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
ALPHA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ALPHA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Keros Therapeutics Inc
NASDAQ:KROS
|
0.005x |
|
Shandong Longda Meat Foodstuff Co Ltd
SHE:002726
|
-0.183x |
|
Legato Merger Corp. IV
NASDAQ:LEGO
|
N/A |
|
FM Mattsson Mora Group AB (publ)
ST:FMM-B
|
0.007x |
|
Jumbo Interactive Ltd
AU:JIN
|
0.185x |
|
Marie Brizard Wine & Spirits
PA:MBWS
|
0.019x |
|
Know Labs Inc.
NYSE MKT:KNW
|
0.269x |
|
Eaton Vance Senior Floating Rate Closed Fund
NYSE:EFR
|
0.128x |
Annual Cash Flow Conversion Efficiency for ALPHA (2020–2025)
The table below shows the annual cash flow conversion efficiency of ALPHA from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of ALPHA.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | RM204.15 Million ≈ $51.25 Million |
RM54.91 Million ≈ $13.79 Million |
0.269x | -13.55% |
| 2024-05-31 | RM189.78 Million ≈ $47.65 Million |
RM59.05 Million ≈ $14.83 Million |
0.311x | -71.99% |
| 2023-05-31 | RM54.55 Million ≈ $13.70 Million |
RM60.61 Million ≈ $15.22 Million |
1.111x | +90.88% |
| 2022-05-31 | RM58.97 Million ≈ $14.80 Million |
RM34.32 Million ≈ $8.62 Million |
0.582x | +152.19% |
| 2021-05-31 | RM48.57 Million ≈ $12.19 Million |
RM11.21 Million ≈ $2.81 Million |
0.231x | -72.30% |
| 2020-05-31 | RM28.36 Million ≈ $7.12 Million |
RM23.63 Million ≈ $5.93 Million |
0.833x | -- |
About ALPHA
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization tre… Read more